The DOI matches its Crossref record.
Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure
Abstract
Background Natriuretic peptides, particularly brain natriuretic peptide (BNP), are elevated in heart failure and therefore considered to be excellent predictors of outcome. Vasopressin is also known to be related to the severity of heart disease. Copeptin – an inactive fragment of the vasopressin precursor – has not been previously investigated in the context of heart failure. Materials and methods We prospectively studied 268 patients with advanced heart failure after they had been discharged from the hospital. We investigated the ability of BNP and copeptin to predict death, re‐hospitalization due to heart failure, and a combination of the two endpoints. Results Over a mean follow‐up period of 15·8 months (up to 24 months), 83 patients died, 122 patients experienced worsening of heart failure, and 145 patients achieved the combined endpoint. Univariate predictors of death were copeptin, BNP, age and impaired kidney function. In multivariate analysis, copeptin (χ 2 = 16,P < 0·0001) and age (χ 2 = 4,P < 0·05) were independent predictors. Univariate predictors of re‐hospitalization due to heart failure were copeptin, BNP, age and impaired kidney function. Furthermore, in multivariate analysis BNP (χ 2 = 18,P < 0·0001), age (χ 2 = 11·8,P < 0·001) and copeptin (χ 2 = 4·2,P < 0·05) were found to be independent predictors. Conclusion Our study is the first to show that copeptin is an excellent predictor of outcome in advanced heart failure patients. Its value is superior to that of BNP in predicting death and a combined endpoint, although BNP is still suitable for predicting chronic heart failure (CHF) re‐hospitalization. Our data imply that vasopressin antagonism might be a new target to improve outcome in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Crespo-Leiro, M. G., Metra, M., Lund, L. H., Milicic, D., Costanzo, M. R., Filippatos, G., Gustafsson, F., Tsui, S., Barge-Caballero, E., De Jonge, N., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1236 · Cited by 880
Self-citationCopeptin: clinical use of a new biomarker
Morgenthaler, N. G., Struck, J., Jochberger, S., & Dünser, M. W. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.11.001 · Cited by 408
Self-citationWilson Tang, W. H., Francis, G. S., Morrow, D. A., Newby, L. K., Cannon, C. P., Jesse, R. L., Storrow, A. B., Christenson, R. H., COMMITTEE MEMBERS, Christenson, R. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.185267 · Cited by 310
Balanescu, S., Kopp, P., Gaskill, M. B., Morgenthaler, N. G., Schindler, C., & Rutishauser, J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2499 · Cited by 246
Self-citationVoors, A. A., von Haehling, S., Anker, S. D., Hillege, H. L., Struck, J., Hartmann, O., Bergmann, A., Squire, I., van Veldhuisen, D. J., Dickstein, K., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp098 · Cited by 222
Self-citation
Metadata
- Authors
- Stoiser, B., Mörtl, D., Hülsmann, M., Berger, R., Struck, J., Morgenthaler, N. G., Bergmann, A., & Pacher, R.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2006-10-09
- Volume
- 36
- Issue
- 11
- Pages
- 771-778
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2167996222
- Cited by
- 226
- References
- 0
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. https://app.cochat.ai/papers/10.1111/j.1365-2362.2006.01724.x
- The paper
- Stoiser, B., Mörtl, D., Hülsmann, M., Berger, R., Struck, J., Morgenthaler, N. G., Bergmann, A., & Pacher, R. (2006). Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2006.01724.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.